← Back to Search

Mind-Body Intervention

Tai Chi for Chronic Pain in Adults with HIV

N/A
Waitlist Available
Led By Eugene M Dunne, PhD
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study if Tai Chi is an effective way to manage chronic pain for people with HIV.

Who is the study for?
This trial is for adults over 45 who are living with HIV and chronic pain, can speak English, and are physically able to do Tai Chi. They must be willing to consent, travel to the study site, and commit to a 10-week program. People with acute mental health crises or active substance use disorders cannot join.
What is being tested?
The study is testing whether Health Coaching and Tai Chi can help improve life quality for those living with HIV and chronic pain. It aims to provide an alternative to opioid-based treatments by exploring these non-drug approaches.
What are the potential side effects?
Since this trial involves non-pharmacological interventions like Health Coaching and Tai Chi, side effects may include muscle soreness or strain from physical activity but typically do not involve drug-related side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brief Pain Inventory - Short Form (BPI)
Orebro Musculoskeletal Pain Screening Questionnaire (OMSPQ)
Pain Rating (VAS)
+1 more
Secondary study objectives
Pain Catastrophizing Scale (PCS)
Patient Health Questionnaire (PHQ-8)
Perceived Stress Scale (PSS)
+3 more
Other study objectives
Acceptability
Feasibility

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gentle MovementExperimental Treatment1 Intervention
Group II: Health CoachingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tai Chi
2014
Completed Phase 2
~1660

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor
315 Previous Clinical Trials
88,917 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
853 Previous Clinical Trials
671,704 Total Patients Enrolled
Eugene M Dunne, PhDPrincipal InvestigatorTemple University
1 Previous Clinical Trials
450 Total Patients Enrolled

Media Library

Tai Chi (Mind-Body Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05055596 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Gentle Movement, Health Coaching
Human Immunodeficiency Virus Infection Clinical Trial 2023: Tai Chi Highlights & Side Effects. Trial Name: NCT05055596 — N/A
Tai Chi (Mind-Body Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05055596 — N/A
~9 spots leftby Nov 2025